Effects of Tea Catechins on Alzheimer’s Disease: Recent Updates and Perspectives
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Alzheimer’s disease (AD) is one of the most common neurodegenerative disorders worldwide. Its incidence is gradually increasing because of an aging demographic. Therefore, AD prevention and modification is important to improve the health status of older adults. Oxidative stress is a component of the pathological mechanisms underlying AD. It is caused by a disruption of the balance between reactive oxygen species and antioxidant molecules. This imbalance also causes neuroinflammation. Catechins, which are bioactive components of tea, have antioxidative and anti-inflammatory effects. Moreover, other potential properties related to AD prevention and modification have been reported in in vitro and in vivo studies. Several clinical studies have also been conducted to date. The current review summarizes recent updates and perspectives of the effects of catechins on AD based on the molecular mechanisms and related clinical studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · cited 1×
“Neuronal inflammation can also be related to the pathogenesis of AD, and could be induced by the inflammatory reaction resulting from amyloid β protein accumulation [30].”
BackgroundSoluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Tea catechins and polyphenols: Health effects, metabolism, and antioxidant functions
Higdon, J. V., & Frei, B. (2003) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408690390826464 · Cited by 1,854 · cited 13×
“In this review article, we only focused on tea catechins, but grape (Vitis vinifera) seeds also include bioactive catechins such as EGCG.”
BackgroundInfluentialAlzheimer Mechanisms and Therapeutic Strategies
Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758 · cited 1×
“Currently, amyloid and tau protein-related neurotoxicity, changes in cholinergic neurotransmission, oxidative stress, and alterations in calcium homeostasis are considered to be key elements of AD [13,14].”
BackgroundAlzheimer's Disease and the Amyloid-β Peptide
Murphy, M. P., & LeVine, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1221 · Cited by 1,750
Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651
The role of oxidative stress in neurodegenerative diseases
Kim, G. H., Kim, J. E., Rhie, S. J., & Yoon, S. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.325 · Cited by 1,355
CENTRAL CHOLINERGIC SYSTEMS AND COGNITION
Everitt, B. J., & Robbins, T. W. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.649 · Cited by 1,348 · cited 1×
“The cerebral cholinergic system is thought to play an essential role in memory in humans [40].”
BackgroundSystemic inflammation and disease progression in Alzheimer disease
Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bb95 · Cited by 1,139 · cited 1×
“Exacerbation of cognitive decline and behavioral changes after systemic inflammation have also been reported in humans [32,33].”
BackgroundRole of oxidative stress in Alzheimer’s disease
HUANG, W.-J., ZHANG, X., & CHEN, W.-W. (2016) · Biomedical Reports · doi:10.3892/br.2016.630 · Cited by 1,023
Inflammation after trauma: Microglial activation and traumatic brain injury
Ramlackhansingh, A. F., Brooks, D. J., Greenwood, R. J., Bose, S. K., Turkheimer, F. E., Kinnunen, K. M., Gentleman, S., Heckemann, R. A., Gunanayagam, K., Gelosa, G., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22455 · Cited by 999
The role of mitochondria in reactive oxygen species metabolism and signaling
Starkov, A. A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.015 · Cited by 846 · cited 1×
“Mitochondria play an important role in maintaining the balance of ROS and antioxidants [28,29].”
BackgroundUpdate on Alzheimer’s Disease Therapy and Prevention Strategies
Graham, W. V., Bonito-Oliva, A., & Sakmar, T. P. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-042915-103753 · Cited by 506 · cited 2×
“In addition, the strategy for AD drug development has recently shifted toward disease prevention rather than treatment [7].”
BackgroundMorales, I., Guzmán-MartÃnez, L., Cerda-Troncoso, C., FarÃas, G. A., & Maccioni, R. B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00112 · Cited by 490
Williams, R. J., & Spencer, J. P. E. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.010 · Cited by 448 · cited 1×
“Hence, catechins and their derivatives have the potential be useful in pharmaceutical and nonpharmaceutical treatment approaches [11,12].”
BackgroundGreen tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project
Kuriyama, S., Hozawa, A., Ohmori, K., Shimazu, T., Matsui, T., Ebihara, S., Awata, S., Nagatomi, R., Arai, H., & Tsuji, I. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.355 · Cited by 428
Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study
Eskelinen, M. H., Ngandu, T., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0920 · Cited by 428
Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection
Singh, M., Kaur, M., Kukreja, H., Chugh, R., Silakari, O., & Singh, D. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.09.050 · Cited by 364
The role of mitochondrial ROS in the aging brain
Stefanatos, R., & Sanz, A. (2018) · FEBS Letters · doi:10.1002/1873-3468.12902 · Cited by 358
Review: Systemic inflammation andAlzheimer's disease
Holmes, C. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01307.x · Cited by 356
Kanekiyo, T., & Bu, G. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00093 · Cited by 281
Nurk, E., Refsum, H., Drevon, C. A., Tell, G. S., Nygaard, H. A., Engedal, K., & Smith, A. D. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.095182 · Cited by 261 · cited 2×
“, 2009 [71] Norwegian residents 70–74 yo (N = 2031); any type of tea (black tea is most common) Dose dependency for the cognitive performance was observed ~200 mL/day”
BackgroundOxidative stress in vascular dementia and Alzheimer’s disease: a common pathology
Bennett, S., Grant, M. M., & Aldred, S. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1041 · Cited by 254
Tea consumption and cognitive impairment and decline in older Chinese adults
Ng, T.-P., Feng, L., Niti, M., Kua, E.-H., & Yap, K.-B. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.1.224 · Cited by 236 · cited 5×
“, 2008 [70] Community-living Chinese ≥55 yo (N = 2501); green, black, and oolong tea Prevalence of cognitive impairment was lower in the frequently tea-drinking group (OR (95% CI) 1; medium-level intake, 0.”
BackgroundInfluentialNoguchi-Shinohara, M., Yuki, S., Dohmoto, C., Ikeda, Y., Samuraki, M., Iwasa, K., Yokogawa, M., Asai, K., Komai, K., Nakamura, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096013 · Cited by 174 · cited 3×
“In contrast to Feng′s study, which focused on an older population, Noguchi-Shinohara conducted a study named the Nakajima Project investigating individuals aged ~70 years at baseline [77].”
MethodResultInfluentialDeregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease
Paula‐Lima, A. C., Brito‐Moreira, J., & Ferreira, S. T. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12304 · Cited by 170 · cited 1×
“With respect to excitatory neurotransmission, glutamate in the synaptic cleft can be increased by the presence of soluble amyloid β oligomers [39], representing another target for AD drug development.”
BackgroundPark, S.-K., Jung, I.-C., Lee, W. K., Lee, Y. S., Park, H. K., Go, H. J., Kim, K., Lim, N. K., Hong, J. T., Ly, S. Y., et al. (2011) · Journal of Medicinal Food · doi:10.1089/jmf.2009.1374 · Cited by 105 · cited 4×
“reported on the effects of the supplement (LGNC-07), which included 1440 mg/day green tea extract [81].”
BackgroundMethodResultInfluentialArab, L., Biggs, M. L., O'Meara, E. S., Longstreth, W. T., Crane, P. K., & Fitzpatrick, A. L. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110431 · Cited by 98
Green Tea Consumption Affects Cognitive Dysfunction in the Elderly: A Pilot Study
Ide, K., Yamada, H., Takuma, N., Park, M., Wakamiya, N., Nakase, J., Ukawa, Y., & Sagesaka, Y. (2014) · Nutrients · doi:10.3390/nu6104032 · Cited by 96 · cited 3×
“Following that, in 2014, our research group conducted a before–after exploratory intervention study [83].”
MethodInfluentialSelf-citationTea drinking and cognitive function in oldest-old Chinese
Feng, L., Li, J., Ng, T.-P., Lee, T.-S., Kua, E.-H., & Zeng, Y. (2012) · The Journal of nutrition, health and aging · doi:10.1007/s12603-012-0077-1 · Cited by 82 · cited 3×
“, 2012 [76] Chinese residents 80–115 yo (N = 7139); any type of tea, 7-y follow-up Cognitive function measured by verbal fluency tests was higher in all time-points for tea drinkers compared to nondrinkers.”
BackgroundInfluentialHuang, C.-Q., Dong, B.-R., Zhang, Y.-L., Wu, H.-M., & Liu, Q.-X. (2009) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e3181b2790b · Cited by 62 · cited 4×
“…tea consumption was significantly associated with lower prevalence of cognitive impairment (≥4 cups/day, OR (95% CI), 0.74 (0.57, 0.98), p = 0.032) Huang et al., 2009 [75] Chinese residents ≥90 yo (N = 681); any type of tea In men, but not in women, lower prevalence of cognitive…”
BackgroundResultInfluentialLiu, X., Du, X., Han, G., & Gao, W. (2017) · Oncotarget · doi:10.18632/oncotarget.17429 · Cited by 60
Cited by
Ferraz, C. R., Carvalho, T. T., Manchope, M. F., Artero, N. A., Rasquel-Oliveira, F. S., Fattori, V., Casagrande, R., & Verri, W. A. (2020) · Molecules · doi:10.3390/molecules25030762 · Cited by 349
Catechin in Human Health and Disease
Isemura, M. (2019) · Molecules · doi:10.3390/molecules24030528 · Cited by 263
Role of natural products for the treatment of Alzheimer’s disease
Noori, T., Dehpour, A. R., Sureda, A., Sobarzo-Sanchez, E., & Shirooie, S. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173974 · Cited by 141
Sharifi-Rad, J., Rapposelli, S., Sestito, S., Herrera-Bravo, J., Arancibia-Diaz, A., Salazar, L. A., Yeskaliyeva, B., Beyatli, A., Leyva-Gómez, G., González-Contreras, C., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091515 · Cited by 125
Sun, Y., Huang, J., Chen, Y., Shang, H., Zhang, W., Yu, J., He, L., Xing, C., & Zhuang, C. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104172 · Cited by 73
Metadata
- Authors
- Ide, K., Matsuoka, N., Yamada, H., Furushima, D., & Kawakami, K.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2018-09-14
- Volume
- 23
- Issue
- 9
- Pages
- 2357
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2889965829
- Cited by
- 102
- References
- 32
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.